Mr. Speaker, the scientific evidence is mounting regarding CCSVI. More clinical trials are about to begin in the United States, and Saskatchewan, New Brunswick and Newfoundland are taking action. More important, neurologists are quietly admitting that their patients are improving.
Canada needs clinical trials for CCSVI that are undertaken in multiple centres across our country, and Canada should be tracking the progress of Canadian MS patients, who felt forced to seek liberation treatment overseas, in a registry for efficacy, improvements in quality of life and side effects. Very quickly, we could have more answers regarding patients' progress at one, three, six months, et cetera.
More important, no Canadian should be denied follow-up care here in Canada. It is unconscionable, unethical and clearly a breach of “do no harm”. Cancelling of appointments and mandatory tests, denial of treatment and threatening of patients must stop.